SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 525.00 |
| Enterprise Value ($M) | 492.78 |
| Book Value ($M) | 278.55 |
| Book Value / Share | 2.10 |
| Price / Book | 1.88 |
| NCAV ($M) | 70.76 |
| NCAV / Share | 0.53 |
| Price / NCAV | 7.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.02 |
| Return on Assets (ROA) | -0.02 |
| Return on Equity (ROE) | -0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.74 |
| Current Ratio | 3.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 238.51 |
| Assets | 446.30 |
| Liabilities | 167.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D | Avista Healthcare Partners III, L.P. | 18.00 | ||
| 13D/A | Ades Alan A. | 17.80 | -15.38 | |
| 13G/A | Soleus Capital Master Fund, L.P. | 8.90 | 32.10 | |
| 13G | Morgan Stanley | 8.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 76,386 | 349,148 | 21.88 | |
| 76,885 | 418,583 | 18.37 | |
| 92,919 | 443,610 | 20.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ONCT – Oncternal Therapeutics, Inc. | ONCY – Oncolytics Biotech Inc. |
| ONVO – Organovo Holdings, Inc. | ORMP – Oramed Pharmaceuticals Inc. |
| OTLK – Outlook Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io